Skip to content
Buy This GLP
← Research
Formats

Is a GLP-1 Cheaper Than Bariatric Surgery?

A historical model compared retail prices with surgical estimates. A separate claims study tracked what insured patients paid over three years.

Editorial profile: Carla MedinaBuy This GLP Editorial Team4 min read
Wegovy or Saxenda at 2023 retail pricesSleeve gastrectomyWithin 9 monthsGastric bypassLess than 1 year

Whether a GLP-1 costs less than bariatric surgery depends on what you pay and how long you take it. A historical U.S. model compared retail drug costs with surgical estimates. A separate insurance claims study measured patients’ out-of-pocket expenses over three years[1] [2].

What the historical retail model found

The researchers used average 2023 national retail drug prices and 2015 procedure cost estimates adjusted for inflation. With those inputs, cumulative Wegovy and Saxenda costs exceeded sleeve gastrectomy within nine months and Roux-en-Y gastric bypass in less than one year. Their lowest-price drug, Byetta, crossed the surgical estimate after around 18 months [1].

Our monthly GLP-1 cost guide explains why a current cash quote or insurance copay can differ from a historical retail price. The model also had limited data on long-term costs and costs related to other conditions, so its break-even points depend on the inputs it used [1].

What insured patients paid out of pocket

A different study used U.S. MarketScan insurance claims from 2016 to 2021 for 6,748 people with type 2 diabetes and BMI of at least 35. Adjusted three-year out-of-pocket health care spending was $7,752 with semaglutide, $5,980 with sleeve gastrectomy and $6,591 with gastric bypass. The study did not find a statistically significant difference in total health care spending across the groups [2].

The breakdown of patient and total spending explains how those measures can diverge. The amounts represent adjusted claims-based estimates across patient groups, so they include more than the purchase price of the medication or procedure alone.

Where endoscopic sleeve gastroplasty fits

Our endoscopic sleeve gastroplasty comparison covers an observational study of a separate procedure and oral semaglutide 14 mg daily. In that cohort, average total weight loss at six months was 12.72% with the procedure and 8.67% with semaglutide. At 12 months, the study did not detect a statistically significant difference. The study did not estimate a cost crossover [3].

How to compare your own costs

The six-month medication cost tool can help you add up recurring charges. For a surgery estimate, ask which facility, anesthesia and follow-up fees the quote covers. Compare both options over the same period and use your expected out-of-pocket amounts for each. A lower monthly medication price pushes the modeled crossover later if the procedure estimate and other costs stay fixed.

Frequently asked

When did medication cost more than surgery in the model?
At average 2023 retail prices, projected spending on Wegovy or Saxenda exceeded sleeve gastrectomy within nine months and gastric bypass in less than a year. Your current prices and insurance may lead to a different result.
What did the three-year insurance claims study find?
Adjusted out-of-pocket health care spending was $7,752 with semaglutide, $5,980 with sleeve gastrectomy and $6,591 with gastric bypass in insured patients with obesity and type 2 diabetes. Total health care spending did not differ significantly.
Can I use those numbers to estimate my own bill?
Use current quotes for your medication dose and procedure, check insurance benefits, and estimate recurring and follow-up costs over the same period.

Sources

  1. [1] Docimo S Jr, et al. (2024). A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point? Surgical Endoscopy. PMID 39285034
  2. [2] Chhabra KR, Gencerliler N, Orandi BJ, Wang VH, et al. (2026). Semaglutide vs. Bariatric Surgery: Comparing Costs and Clinical Outcomes in Patients With Diabetes and Obesity Obesity (Silver Spring, Md.). PMID 42089543
  3. [3] Jagtap N, Golchha A, Katrevula A, Asif S, et al. (2026). Endoscopic sleeve gastroplasty versus oral semaglutide for obesity: a real-world comparative cohort study Endoscopy. PMID 42259388

Where to get it

The cheapest GLP-1

Every seller that publishes a price, ordered lowest first on the standing month-to-month rate, plus the question to ask before you pay any of them.

See the board →

More in Formats